Depression and anxiety during the perinatal period.
Depression and anxiety during the perinatal period.
复制标题
DOI：
10.1186/s12888-015-0526-6
复制
发表时间：
2015-08-25
期刊：
影响因子：
4.4
通讯作者：
Tucker E
中科院分区：
文献类型：
--
作者：
Fairbrother N;Young AH;Janssen P;Antony MM;Tucker E
情绪和焦虑及相关障碍（AD）在心理健康状况中占很大比例，近30%的人口（28.8%）在一生中的某个时候患有AD，超过百分之十五（16.2%）患有情绪障碍。现有的实证文献留下了一些重要的差距，我们的理解情绪，焦虑和压力相关的困难，孕妇和产后妇女。本研究的目的就是解决这些问题。参与者是660名讲英语的孕妇。估计围产期情绪障碍和AD患病率/发病率的研究部分的参与者（N = 347）按比例从地理定义的区域招募。所有参与者都是通过在医院、医生办公室和助产诊所的产前诊所访问，以及通过活动中的社区外展和口口相传招募的。招募于2007年11月9日至2010年11月12日进行。参与者在产前的两个时间点（大约妊娠24周和33周）以及产后4-6周和产后6个月再次接受问卷调查。在4-6周情绪和焦虑问卷中的一个或多个上筛选高于截止值的患病率/发病率研究参与者还在产后约8-12周进行情绪障碍和AD的诊断性访谈。这项研究解决了我们对孕妇和产后妇女情绪，焦虑和压力的理解方面的一些差距。具体而言，我们的知识差距的患病率和发病率（a）AD和情绪障碍，（B）焦虑和压力的妇女经历了医学上的高风险怀孕，在怀孕期间的压力管理培训的兴趣，心理健康治疗的障碍和访问和筛查焦虑的孕妇和产后妇女解决。这一系列研究的结果有可能改善孕妇和产后妇女情绪和焦虑问题的筛查、评估和治疗。
Mood and anxiety and related disorders (AD) account for a significant proportion of mental health conditions, with close to 30 % of the population (28.8 %) suffering from an AD at some time in their life, and over fifteen percent (16.2 %) suffering from a mood disorder. The existing empirical literature leaves a number of important gaps with respect to our understanding of mood, anxiety and stress related difficulties among pregnant and postpartum women. The objective of this research is to address these. Participants were 660 English-speaking pregnant women. Participants for the portion of the research estimating the prevalence/incidence of perinatal mood disorders and AD (N = 347) were recruited proportionally from a geographically defined area. All participants were recruited via prenatal clinic visits at hospitals, physician offices and midwifery clinics, and via community outreach at events and through word of mouth. Recruitment took place between November 9, 2007 and November 12, 2010. Participants were administered questionnaires prenatally at two time points (approximately 24 and 33 weeks gestation) and again at 4–6 weeks’ postpartum and 6-months postpartum. Prevalence/incidence study participants who screened above cut-off on one or more of the 4–6 week mood and anxiety questionnaires were also administered a diagnostic interview for mood disorders and AD at approximately 8–12 weeks postpartum. This research addresses a number of gaps in our understanding of mood, anxiety and stress among pregnant and postpartum women. Specifically, gaps in our knowledge regarding the prevalence and incidence of (a) AD and mood disorders, and (b) anxiety and stress among women experiencing a medically high-risk pregnancy, interest in stress management training in pregnancy, mental health treatment barriers and access and screening for anxiety among pregnant and postpartum women are addressed. The findings from this series of studies have the potential to improve screening, assessment and treatment of mood and anxiety problems suffered by pregnant and postpartum women.